VALN Stock Posts

VALN Valneva Se - American Depositary Shares5.87+0.01+0.2%

After Hours:5.61-0.26 (-4.4%)

Valneva Provides Update on IXCHIQ in the United Kingdom

Globe NewswireWed, 7-Oct 4:00 PM

VALN Valneva Se - American Depositary Shares5.87+0.01+0.2%

After Hours:5.61-0.26 (-4.4%)

Valneva Provides Update on IXCHIQ in the United Kingdom

Globe NewswireWed, 7-Oct 4:00 PM

VALN Valneva Se - American Depositary Shares7.13+1.48+26.2%

After Hours:6.79-0.34 (-4.8%)

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Globe NewswireFri, 14-Aug 1:00 AM

VALN Valneva Se - American Depositary Shares10.32-0.18-1.7%

Premarket:6.70-3.62 (-35.1%)

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Business WireMon, 23-Mar 6:45 AM

VALN Valneva Se - American Depositary Shares9.43-2.21-19.0%

Premarket:8.95-0.48 (-5.1%)

Valneva Announces FDA's Decision to Suspend License of Chikungunya Vaccine IXCHIQ in the U.S.

Globe NewswireMon, 25-Aug 1:00 AM

VALN Valneva Se - American Depositary Shares11.64+0.45+4.0%

Premarket:9.23-2.41 (-20.7%)

Valneva Announces FDA's Decision to Suspend License of Chikungunya Vaccine IXCHIQ in the U.S.

Globe NewswireMon, 25-Aug 1:00 AM